Skip to main content
Top
Published in: Infection 5/2017

01-10-2017 | Original Paper

Can a collaborative subspecialty antimicrobial stewardship intervention have lasting effects?

Authors: Kaushal B. Shah, Ramzy H. Rimawi, Mark A. Mazer, Paul P. Cook

Published in: Infection | Issue 5/2017

Login to get access

Abstract

Objective

We previously demonstrated the benefit of direct, daily collaboration between infectious disease (ID) and critical care practitioners (CCP) on guideline adherence and antibiotic use in the medical intensive care unit (MICU). In this post-intervention review, we sought to establish whether the effect on antibiotic use and guideline adherence was sustainable.

Design

A retrospective review of 87 patients, admitted to the 24-bed MICU, was done 3 (n = 45) and 6 months (n = 42) after the intervention.

Measurements

Data included demographics, severity indicators, admitting pathology, infectious diagnosis, clinical outcomes [mechanical ventilation days (MVD) and MICU length of stay (LOS), antibiotic days of therapy (DOT), in-hospital mortality], and antibiotic appropriateness based on current guidelines.

Results

In the 3-month (3-PI) and 6-month post-intervention (6-PI), there were no significant differences in the APACHE II score, MVD, LOS, DOT, or total antibiotic use at 3 (p = 0.59) and 6-PI (p = 0.87). There was no change in the mean use of extended-spectrum penicillins, cephalosporin, and carbapenems. While there were significant differences in vancomycin usage at 3-PI [3.1 DOT vs. 4.3 DOT (p = 0.007)], this finding was not seen after 6 months [3.1 DOT vs. 3.4 DOT (p = 0.08)]. When compared to the intervention period, the inappropriateness of antibiotic use at 3 (p = 1.00) and 6-PI (p = 0.30) did not change significantly.

Conclusions

There were no significant differences in either total antibiotic use or inappropriate antibiotic use at the 6-PI time period. Continuous, daily, direct collaboration between ID and CCP, once implemented, can have lasting effects even at 6 months after the interaction has been discontinued.
Literature
1.
go back to reference Tamma PD, Cosgrove SE. Antimicrobial stewardship. Infect Dis Clin N Am. 2011;25:245–60.CrossRef Tamma PD, Cosgrove SE. Antimicrobial stewardship. Infect Dis Clin N Am. 2011;25:245–60.CrossRef
2.
go back to reference Curcio D. Antibiotic stewardship: the “real world” when resources are limited. Infect Control Hosp Epidemiol. 2010;31:666–8.CrossRefPubMed Curcio D. Antibiotic stewardship: the “real world” when resources are limited. Infect Control Hosp Epidemiol. 2010;31:666–8.CrossRefPubMed
3.
go back to reference Martin CA, Armistead JA, Mynatt RP, et al. Moving antimicrobial stewardship from restriction to facilitation. Am J Health Syst Pharm. 2011;68:109–10.CrossRefPubMed Martin CA, Armistead JA, Mynatt RP, et al. Moving antimicrobial stewardship from restriction to facilitation. Am J Health Syst Pharm. 2011;68:109–10.CrossRefPubMed
4.
go back to reference Goldstein EJ. Beyond the target pathogen: ecological effects of the hospital formulary. Curr Opin Infect Dis. 2011;24:S21–31.CrossRefPubMed Goldstein EJ. Beyond the target pathogen: ecological effects of the hospital formulary. Curr Opin Infect Dis. 2011;24:S21–31.CrossRefPubMed
6.
go back to reference Young MK, Buising KL, Cheng AC. Improved susceptibility of gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system. J Antimicrob Chemother. 2010;65:1062–9.CrossRef Young MK, Buising KL, Cheng AC. Improved susceptibility of gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system. J Antimicrob Chemother. 2010;65:1062–9.CrossRef
7.
go back to reference Rimawi RH, Mazer MA, Siraj DS, et al. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med. 2013;41:2099–107.CrossRefPubMed Rimawi RH, Mazer MA, Siraj DS, et al. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med. 2013;41:2099–107.CrossRefPubMed
8.
go back to reference Mandell LA, Wunderink RG, Anzueto A, et al. Community-acquired pneumonia in adults: guidelines for management. Clin Infec Dis. 2007;44:S27–72.CrossRef Mandell LA, Wunderink RG, Anzueto A, et al. Community-acquired pneumonia in adults: guidelines for management. Clin Infec Dis. 2007;44:S27–72.CrossRef
9.
go back to reference American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416.CrossRef American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416.CrossRef
10.
go back to reference Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156:196–200.CrossRefPubMed Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156:196–200.CrossRefPubMed
11.
go back to reference Solomkim JS, Mazuski JE, Bradley JS, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2010;501:133–64.CrossRef Solomkim JS, Mazuski JE, Bradley JS, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2010;501:133–64.CrossRef
12.
go back to reference Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women. A 2010 update by the infectious diseases society of america and the european society for microbiology and infectious diseases. Clin Infect Dis. 2011;52:e103–210.CrossRefPubMed Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women. A 2010 update by the infectious diseases society of america and the european society for microbiology and infectious diseases. Clin Infect Dis. 2011;52:e103–210.CrossRefPubMed
13.
go back to reference Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infection Diseases Society of America. Clin Infec Dis. 2010;50:625–63.CrossRef Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infection Diseases Society of America. Clin Infec Dis. 2010;50:625–63.CrossRef
15.
go back to reference Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, SchaffinoCano S, Galvez-Vargas R. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med. 1994;22:55–60.CrossRefPubMed Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, SchaffinoCano S, Galvez-Vargas R. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med. 1994;22:55–60.CrossRefPubMed
16.
go back to reference Raineri E, Pan A, Mondello P, et al. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Am J Infect Control. 2008;36:283–90.CrossRefPubMed Raineri E, Pan A, Mondello P, et al. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Am J Infect Control. 2008;36:283–90.CrossRefPubMed
17.
go back to reference Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin Chest Med. 1999;20:303–16.CrossRefPubMed Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin Chest Med. 1999;20:303–16.CrossRefPubMed
18.
go back to reference Nicolau DP. Current challenges in the management of the infected patient. Curr Opin Infect Dis. 2011;24:S1–10.CrossRefPubMed Nicolau DP. Current challenges in the management of the infected patient. Curr Opin Infect Dis. 2011;24:S1–10.CrossRefPubMed
19.
go back to reference Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis. 1988;157:869–76.CrossRefPubMed Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis. 1988;157:869–76.CrossRefPubMed
20.
go back to reference Shlaes DM, Gerding DN, John JF, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25:584–99.CrossRefPubMed Shlaes DM, Gerding DN, John JF, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25:584–99.CrossRefPubMed
21.
go back to reference Lawton RM, Fridkin SK, Gaynes RP, et al. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997. SHEA/IDSA position paper recommendations. Infect Control Hosp Epidemiol. 2000;21:256–9.CrossRefPubMed Lawton RM, Fridkin SK, Gaynes RP, et al. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997. SHEA/IDSA position paper recommendations. Infect Control Hosp Epidemiol. 2000;21:256–9.CrossRefPubMed
22.
go back to reference Girouard S, Levine G, Goodrich K, et al. Infection control programs at children’s hospitals: a description of structures and processes. Am J Infect Control. 2001;29:145–51.CrossRefPubMed Girouard S, Levine G, Goodrich K, et al. Infection control programs at children’s hospitals: a description of structures and processes. Am J Infect Control. 2001;29:145–51.CrossRefPubMed
23.
go back to reference Sunenshine RH, Liedtke LA, Jernigan DB, et al. Role of infectious disease consultants in management of antimicrobial use in hospitals. Clin Infect Dis. 2004;38:934–8.CrossRefPubMed Sunenshine RH, Liedtke LA, Jernigan DB, et al. Role of infectious disease consultants in management of antimicrobial use in hospitals. Clin Infect Dis. 2004;38:934–8.CrossRefPubMed
24.
go back to reference Schmitt S, McQuillen DP, Nahass R. Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs. Clin Infect Dis. 2013;58:22–8 (Epub ahead of print).CrossRefPubMed Schmitt S, McQuillen DP, Nahass R. Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs. Clin Infect Dis. 2013;58:22–8 (Epub ahead of print).CrossRefPubMed
25.
go back to reference Srinivasan A. Engaging hospitalist in antimicrobial stewardship: the CDC perspective. J Hosp Med. 2011;6:S31–3.CrossRefPubMed Srinivasan A. Engaging hospitalist in antimicrobial stewardship: the CDC perspective. J Hosp Med. 2011;6:S31–3.CrossRefPubMed
26.
go back to reference Toth NR, Chambers RM, Davis SL. Implementation of a care bundle for antimicrobial stewardship. Am J Health Syst Pharm. 2010;67:746–9.CrossRefPubMed Toth NR, Chambers RM, Davis SL. Implementation of a care bundle for antimicrobial stewardship. Am J Health Syst Pharm. 2010;67:746–9.CrossRefPubMed
27.
28.
go back to reference Owens RC Jr. Antimicrobial stewardship: concepts and strategies in the 21st century. Diagn Microbiol Infect Dis. 2008;61:110–28.CrossRefPubMed Owens RC Jr. Antimicrobial stewardship: concepts and strategies in the 21st century. Diagn Microbiol Infect Dis. 2008;61:110–28.CrossRefPubMed
29.
go back to reference Paterson DL. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis. 2006;42:S90–5.CrossRefPubMed Paterson DL. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis. 2006;42:S90–5.CrossRefPubMed
30.
31.
go back to reference Goff DA. Antimicrobial stewardship: bridging the gap between quality care and cost. Curr Opin Infect Dis. 2011;24:S11–20.CrossRefPubMed Goff DA. Antimicrobial stewardship: bridging the gap between quality care and cost. Curr Opin Infect Dis. 2011;24:S11–20.CrossRefPubMed
32.
go back to reference Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.CrossRefPubMed Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.CrossRefPubMed
33.
go back to reference Höffken G, Niederman MS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest. 2002;122:2183–96.CrossRefPubMed Höffken G, Niederman MS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest. 2002;122:2183–96.CrossRefPubMed
Metadata
Title
Can a collaborative subspecialty antimicrobial stewardship intervention have lasting effects?
Authors
Kaushal B. Shah
Ramzy H. Rimawi
Mark A. Mazer
Paul P. Cook
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1047-7

Other articles of this Issue 5/2017

Infection 5/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.